RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Efficacy of Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers in the Management of Left Ventricular Systolic Dysfunction According to Race, Gender and Diabetic Status: A Meta-Analysis of Major Clinical Trials
Shekelle, P., Rich, M., Morton, S., Atkinson, S., Tu, W., Maglione, M., Rhodes, S., Barrett, M., Fonarow, G., Greenberg, B., Heidenreich, P., Knabel, T., Konstam, M., Steimle, A., & Stevenson, L. (2003). Efficacy of Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers in the Management of Left Ventricular Systolic Dysfunction According to Race, Gender and Diabetic Status: A Meta-Analysis of Major Clinical Trials. Journal of the American College of Cardiology, Vol. 41(No. 9), 1529 - 1538.